Polycystic ovary syndrome (PCOS) is among the most common endocrinopathies in reproductive-age women, with a reported prevalence between 6 and 10%. Although there are modest variations between specific diagnostic criteria (1, 2), it is clear that PCOS (however defined), carries with it a significant risk for metabolic disturbances that include both prediabetes as well as frank type 2 diabetes; individual components of the metabolic syndrome are also seen with greater frequency in PCOS women compared to controls (1-3).
http://ift.tt/2k6cVij
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου